The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of …

SR Mehta - European heart journal, 2000 - europepmc.org
Background Other than aspirin, there are few oral antithrombotic treatments with proven
efficacy in patients with acute coronary syndrome. In this report, we present the rationale …
被引用次数：480 相关文章

The clopidogrel in unstable angina to prevent Recurrent Events (CURE) trial programme-Rationale, design and baseline characteristicsincluding a meta-analysis of …

S Yusuf, SR Mehta, S Anand, A Avezum… - EUROPEAN HEART …, 2000 - real.mtak.hu
Background Other than aspirin, there are few oral antithrombotic treatments with proven
efficacy in patients with acute coronary syndrome. In this report, we present the rationale …

The clopidogrel in unstable angina to prevent Recurrent Events (CURE) trial programme-Rationale, design and baseline characteristics including a meta-analysis of …

S Yusuf, S Mehta, S Anand, A Avezum, N Awan… - EUROPEAN HEART …, 2000 - iris.unisr.it
Background Other than aspirin, there are few oral antithrombotic treatments with proven
efficacy in patients with acute coronary syndrome. In this report, we present the rationale …

[引用][C] The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta …

JA Marin-Neto - European Heart Journal, 2000 - repositorio.usp.br
ReP USP - Detalhe do registro: The clopidogrel in unstable angina to prevent recurrent
events (CURE) trial programme: Rationale, design and baseline characteristics including a …

[引用][C] The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta …

SR Mehta, S Yusuf - European Heart Journal, 2000 - cir.nii.ac.jp
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme.
Rationale, design and baseline characteristics including a meta-analysis of the effects of …

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of …

SR Mehta, S Yusuf… - European heart …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Other than aspirin, there are few oral antithrombotic treatments with proven
efficacy in patients with acute coronary syndrome. In this report, we present the rationale …

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of …

S Yusuf, S Mehta, S Anand… - European heart …, 2000 - mayoclinic.elsevierpure.com
Background: Other than aspirin, there are few oral antithrombotic treatments with proven
efficacy in patients with acute coronary syndrome. In this report, we present the rationale …

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of …

S Yusuf, S Mehta, S Anand… - European heart …, 2000 - mayoclinic.pure.elsevier.com
Background: Other than aspirin, there are few oral antithrombotic treatments with proven
efficacy in patients with acute coronary syndrome. In this report, we present the rationale …